Stasys has developed the Atlas Platelet Strength Test, a microfluidics-based system that measures platelet strength in a native blood sample within three minutes, without the need for external reagents. This technology provides rapid, actionable insights into bleeding risk and transfusion needs, enabling clinicians to make informed decisions during critical care situations.
Funding
$1.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current platelet function tests often assess only a single step in platelet aggregation, require 30-60 minutes to complete, and involve cumbersome procedures with external reagents. These limitations hinder rapid assessment of bleeding risk and timely clinical decision-making in critical care situations.
Solution
The Stasys Atlas Platelet Strength Test (PST) is a microfluidics-based system that measures platelet strength in a native blood sample within three minutes, eliminating the need for external reagents. The system provides a global assessment of primary hemostasis by measuring the end product of platelet adhesion, activation, aggregation, and contraction. By measuring platelet strength, the Atlas PST offers a more accurate and in-depth assessment of primary hemostasis, enabling clinicians to make rapid, informed decisions regarding bleeding risk and transfusion needs. The test leverages high-precision microfluidics with machine vision and machine learning to provide faster, more accurate results at the point of care.
Target Audience
The primary users are trauma doctors and clinicians in critical care settings who require rapid and accurate assessment of platelet function to guide transfusion decisions and manage bleeding risk.
Features
- Measures platelet strength in a native blood sample within 3 minutes
- Eliminates the need for external reagents, simplifying the testing process
- Leverages high-precision microfluidics with machine vision and machine learning for accurate results
- Provides a global assessment of primary hemostasis, measuring the end product of platelet function
- Benchtop machine designed for point-of-care testing
- Measures the dose response to common platelet inhibitors and anticoagulants, including Aspirin, Heparin, and Plavix (clopidogrel)